SureSeq myPanel™ NGS Custom FH Panels enable streamlined investigation of FH and customisation of content Oxford, UK. Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its customisable SureSeq™ NGS panel range with the launch of the SureSeq myPanel™ NGS Custom FH Panel – allowing fast and cost-effective study of variants in familial hypercholesterolemia (FH). The new panel […]

We’ve launched a new metagenomics analysis plugin for our Microbial Genomics Pro Suite and CLC Genomics Workbench. Developed by CosmosID, the plugin is particularly helpful for those working with complex metagenomics samples, when identifying genes involved in virulence or antibiotic resistance, for example, is crucial.   QIAGEN and CosmosID launch new plugin for metagenomics analysis […]

SINGAPORE, BEIJING, and SAN DIEGO — Novogene, a leading commercial provider of genomic services and solutions with cutting edge next-generation sequencing and bioinformatics expertise; AITbiotech Pte Ltd, a Singaporebiotechnology company; and the Genome Institute of Singapore (GIS) announced today that NovogeneAIT Genomics Singapore (NovogeneAIT) – a new joint venture between Novogene and AITbiotech – will establish a […]

Washington University School of Medicine first partner to adopt company-centric workflow for immuno-oncology research  CARLSBAD, Calif.–Thermo Fisher Scientific today announced its Center of Excellence in Immunotherapy Program designed to build strategic collaborations and accelerate research and clinical trials in immuno-oncology around the globe. The Washington University School of Medicine is the first institution to partner […]

SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Sam A. Samad, Senior Vice President and Chief Financial Officer. He will join the company on January 6th, 2017. Sam will be responsible for the company’s finance, accounting, investor relations, internal audit and treasury functions. He joins Illumina from Cardinal Health where he held several senior leadership positions including most recently […]

IP Group plc (LSE: IPO) (“IP Group” or “the Group”), the developer of intellectual property-based businesses, is pleased to note that portfolio company Genomics plc (“Genomics”) and Oxford University’s Wellcome Trust Centre for Human Genetics (“WTCHG”) confirmed they have sequenced and analysed multiple human genomes using hand-held technology from portfolio company Oxford Nanopore Technologies Ltd (“Nanopore”). Using […]

Illumina Will Partner with Foundation for the Children of the Californias, Rare Genomics Institute, and UCSF Benioff Children’s Hospital San Francisco, to Sequence the Genomes of Nearly 100 Patients and Their Parents in Inaugural Year SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced the iHope program, a philanthropic initiative aimed at identifying the genetic causes of undiagnosed […]

Demonstrates potential for wide-scale whole-genome sequencing in humans using nanopore approaches Oxford, UK: Oxford University’s Wellcome Trust Centre for Human Genetics (WTCHG) and the leading genome analytics company Genomics plc today announced the first sequencing and analysis of multiple human genomes using nanopore technology. The announcement, made on Thursday at the Oxford Nanopore Community Meeting in […]

Pleasanton, CA Roche (SIX: RO, ROG; OTCQX: RHHBY)today announced an expansion of their distribution alliance with the life science business of Merck KGaA, Darmstadt, Germany, to now include the qPCR and endpoint PCR portfolios1 from Kapa Biosystems.  Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the US and Canada.  Kapa Biosystems was previously acquired by Roche […]

SAN DIEGO – Edico Genome, creator of the world’s first bio-IT processor designed to analyze next-generation sequencing data, today announced that they are deploying DRAGEN on AWS’ newly available Amazon EC2 F1 instances, which are Field Programmable Gate Array (FPGA)-enabled instances in the cloud, potentially reducing analysis times from 26 minutes for a whole genome to real […]